Technical Analysis for SAVA - Cassava Sciences, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 29.59 | -4.30% | -1.33 |
SAVA closed down 4.3 percent on Monday, February 6, 2023, on 55 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline.
Earnings due: Feb 27
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Flat | Down | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 200 DMA | Bearish | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Multiple of Ten Bearish | Other | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Fell Below 20 DMA | Bearish | -4.30% | |
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -4.30% | |
MACD Bullish Signal Line Cross | Bullish | -4.30% | |
Inside Day | Range Contraction | -4.30% | |
Wide Bands | Range Expansion | -4.30% | |
Crossed Above 20 DMA | Bullish | -6.12% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
Possible NR7 | about 4 hours ago |
Fell Below 200 DMA | about 5 hours ago |
200 DMA Support | about 6 hours ago |
60 Minute Opening Range Breakdown | about 7 hours ago |
Down 3% | about 7 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 02/27/2023
Cassava Sciences, Inc. develops drugs for nervous system disorders in the United States. It engages in developing FENROCK, a proprietary abuse-deterrent transdermal pain patch for pain relief; PTI-125, a small molecule drug candidate to treat Alzheimer's disease; and PTI-125DX, a blood-based diagnostic/biomarker to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was founded in 1998 and is based in Austin, Texas.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Pain Neuroscience Alzheimer's Disease Mental Health Biomarkers Psychiatric Diagnosis Nervous System Disorders Psychiatry Transdermal Abnormal Psychology
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Pain Neuroscience Alzheimer's Disease Mental Health Biomarkers Psychiatric Diagnosis Nervous System Disorders Psychiatry Transdermal Abnormal Psychology
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 62.49 |
52 Week Low | 13.84 |
Average Volume | 1,512,037 |
200-Day Moving Average | 29.67 |
50-Day Moving Average | 33.33 |
20-Day Moving Average | 31.33 |
10-Day Moving Average | 28.98 |
Average True Range | 2.82 |
RSI | 45.65 |
ADX | 15.04 |
+DI | 24.80 |
-DI | 22.20 |
Chandelier Exit (Long, 3 ATRs) | 30.06 |
Chandelier Exit (Short, 3 ATRs) | 34.18 |
Upper Bollinger Bands | 37.20 |
Lower Bollinger Band | 25.46 |
Percent B (%b) | 0.35 |
BandWidth | 37.48 |
MACD Line | -1.03 |
MACD Signal Line | -1.08 |
MACD Histogram | 0.0475 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 31.87 | ||||
Resistance 3 (R3) | 32.06 | 31.49 | 31.49 | ||
Resistance 2 (R2) | 31.49 | 30.91 | 31.40 | 31.36 | |
Resistance 1 (R1) | 30.54 | 30.55 | 30.26 | 30.35 | 31.24 |
Pivot Point | 29.97 | 29.97 | 29.83 | 29.88 | 29.97 |
Support 1 (S1) | 29.02 | 29.39 | 28.74 | 28.83 | 27.94 |
Support 2 (S2) | 28.45 | 29.03 | 28.36 | 27.82 | |
Support 3 (S3) | 27.50 | 28.45 | 27.69 | ||
Support 4 (S4) | 27.31 |